Spherox (spheroids of human autologous matrix-associated chondrocytes)
ATMP
- Region
- 🇪🇺 EU
- Active substance
- spheroids of human autologous matrix-associated chondrocytes
- Company
- CO.DON Gmbh
- Status
- Authorised
- Therapeutic area
- Cartilage Diseases
- CHMP opinion
- Thu 18 May 2017
- EU approval
- Mon 10 Jul 2017
- Designations
- ATMP
- Application
- EMEA/H/C/002736
- ATC
- M09AX02
- Official record
- www.ema.europa.eu
Indication
Repair of symptomatic articular cartilage defects of the femoral condyle and the patella of the knee (International Cartilage Repair Society [ICRS] grade III or IV) with defect sizes up to 10 cm2 in adults.
Regulatory milestones
No milestones recorded in the last year.
Follow Spherox
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.